Conventional SLA and chemically modified SLA implants in patients with poorly controlled type 2 diabetes mellitus--a randomized controlled trial.
Identifieur interne : 000D85 ( PubMed/Corpus ); précédent : 000D84; suivant : 000D86Conventional SLA and chemically modified SLA implants in patients with poorly controlled type 2 diabetes mellitus--a randomized controlled trial.
Auteurs : Namita Khandelwal ; Thomas W. Oates ; Adriana Vargas ; Peggy P. Alexander ; John D. Schoolfield ; C. Alex McmahanSource :
- Clinical oral implants research [ 1600-0501 ] ; 2013.
English descriptors
- KwdEn :
- Acid Etching, Dental, Adult, Aged, Dental Implantation, Endosseous (instrumentation), Dental Implantation, Endosseous (methods), Dental Implants, Dental Prosthesis Design, Diabetes Mellitus, Type 2 (complications), Female, Humans, Jaw, Edentulous, Partially (rehabilitation), Male, Middle Aged, Surface Properties, Treatment Outcome, Wound Healing.
- MESH :
- chemical : Dental Implants.
- complications : Diabetes Mellitus, Type 2.
- instrumentation : Dental Implantation, Endosseous.
- methods : Dental Implantation, Endosseous.
- rehabilitation : Jaw, Edentulous, Partially.
- Acid Etching, Dental, Adult, Aged, Dental Prosthesis Design, Female, Humans, Male, Middle Aged, Surface Properties, Treatment Outcome, Wound Healing.
Abstract
The objective of this study was to evaluate the potential for a chemically modified Sand blasted, Large grit, Acid etched (SLA) surface, compared with a conventional SLA surface, to enhance implant healing and integration in poorly controlled diabetic patients, a group previously demonstrated to have compromises and delays in implant stabilization during the metabolically active healing period following implant placement.
DOI: 10.1111/j.1600-0501.2011.02369.x
PubMed: 22145978
Links to Exploration step
pubmed:22145978Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Conventional SLA and chemically modified SLA implants in patients with poorly controlled type 2 diabetes mellitus--a randomized controlled trial.</title><author><name sortKey="Khandelwal, Namita" sort="Khandelwal, Namita" uniqKey="Khandelwal N" first="Namita" last="Khandelwal">Namita Khandelwal</name><affiliation><nlm:affiliation>Graduate School of Biomedical Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Oates, Thomas W" sort="Oates, Thomas W" uniqKey="Oates T" first="Thomas W" last="Oates">Thomas W. Oates</name></author><author><name sortKey="Vargas, Adriana" sort="Vargas, Adriana" uniqKey="Vargas A" first="Adriana" last="Vargas">Adriana Vargas</name></author><author><name sortKey="Alexander, Peggy P" sort="Alexander, Peggy P" uniqKey="Alexander P" first="Peggy P" last="Alexander">Peggy P. Alexander</name></author><author><name sortKey="Schoolfield, John D" sort="Schoolfield, John D" uniqKey="Schoolfield J" first="John D" last="Schoolfield">John D. Schoolfield</name></author><author><name sortKey="Alex Mcmahan, C" sort="Alex Mcmahan, C" uniqKey="Alex Mcmahan C" first="C" last="Alex Mcmahan">C. Alex Mcmahan</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:22145978</idno><idno type="pmid">22145978</idno><idno type="doi">10.1111/j.1600-0501.2011.02369.x</idno><idno type="wicri:Area/PubMed/Corpus">000D85</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D85</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Conventional SLA and chemically modified SLA implants in patients with poorly controlled type 2 diabetes mellitus--a randomized controlled trial.</title><author><name sortKey="Khandelwal, Namita" sort="Khandelwal, Namita" uniqKey="Khandelwal N" first="Namita" last="Khandelwal">Namita Khandelwal</name><affiliation><nlm:affiliation>Graduate School of Biomedical Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Oates, Thomas W" sort="Oates, Thomas W" uniqKey="Oates T" first="Thomas W" last="Oates">Thomas W. Oates</name></author><author><name sortKey="Vargas, Adriana" sort="Vargas, Adriana" uniqKey="Vargas A" first="Adriana" last="Vargas">Adriana Vargas</name></author><author><name sortKey="Alexander, Peggy P" sort="Alexander, Peggy P" uniqKey="Alexander P" first="Peggy P" last="Alexander">Peggy P. Alexander</name></author><author><name sortKey="Schoolfield, John D" sort="Schoolfield, John D" uniqKey="Schoolfield J" first="John D" last="Schoolfield">John D. Schoolfield</name></author><author><name sortKey="Alex Mcmahan, C" sort="Alex Mcmahan, C" uniqKey="Alex Mcmahan C" first="C" last="Alex Mcmahan">C. Alex Mcmahan</name></author></analytic><series><title level="j">Clinical oral implants research</title><idno type="eISSN">1600-0501</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acid Etching, Dental</term><term>Adult</term><term>Aged</term><term>Dental Implantation, Endosseous (instrumentation)</term><term>Dental Implantation, Endosseous (methods)</term><term>Dental Implants</term><term>Dental Prosthesis Design</term><term>Diabetes Mellitus, Type 2 (complications)</term><term>Female</term><term>Humans</term><term>Jaw, Edentulous, Partially (rehabilitation)</term><term>Male</term><term>Middle Aged</term><term>Surface Properties</term><term>Treatment Outcome</term><term>Wound Healing</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Dental Implants</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Diabetes Mellitus, Type 2</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Dental Implantation, Endosseous</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Dental Implantation, Endosseous</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Jaw, Edentulous, Partially</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acid Etching, Dental</term><term>Adult</term><term>Aged</term><term>Dental Prosthesis Design</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Surface Properties</term><term>Treatment Outcome</term><term>Wound Healing</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this study was to evaluate the potential for a chemically modified Sand blasted, Large grit, Acid etched (SLA) surface, compared with a conventional SLA surface, to enhance implant healing and integration in poorly controlled diabetic patients, a group previously demonstrated to have compromises and delays in implant stabilization during the metabolically active healing period following implant placement.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22145978</PMID><DateCompleted><Year>2013</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2013</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0501</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Clinical oral implants research</Title><ISOAbbreviation>Clin Oral Implants Res</ISOAbbreviation></Journal><ArticleTitle>Conventional SLA and chemically modified SLA implants in patients with poorly controlled type 2 diabetes mellitus--a randomized controlled trial.</ArticleTitle><Pagination><MedlinePgn>13-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1600-0501.2011.02369.x</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this study was to evaluate the potential for a chemically modified Sand blasted, Large grit, Acid etched (SLA) surface, compared with a conventional SLA surface, to enhance implant healing and integration in poorly controlled diabetic patients, a group previously demonstrated to have compromises and delays in implant stabilization during the metabolically active healing period following implant placement.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study enrolled 24 patients with type 2 diabetes, baseline HbA1c levels between 7.5-11.4%, and a minimum of two posterior mandibular tooth sites at least 4 months following extraction and appropriate for implant placement. Each patient, at a randomly selected site, received an implant with the conventional SLA surface; at the second site, the patient received an implant with the chemically modified SLA (modSLA) surface. Thus, 48 study implants were placed. Implant stability was assessed using Resonance Frequency Analysis (RFA). Readings were taken from the buccal and proximal directions for each implant. Implant stability (ISQ) was assessed at the time of surgical placement (baseline) and 2, 3, 4, 6, 8, 10, 12, and 16 weeks following implant placement.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">No significant differences in implant stability were observed between conventional SLA implants and modSLA implants, and the time courses of implant stabilization following implant placement were similar for the two implant types. Baseline ISQ and minimum ISQ was slightly higher in subjects with higher HbA1c levels, but were similar during 12-16 weeks following implant placement. Forty-seven (98%) of the 48 implants were determined to be successfully osseointegrated and continued to restoration.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Implant stabilization was similar for the conventional SLA and chemically modified SLA implants in type 2 diabetic patients with relatively poor glycemic control. Furthermore, this study demonstrated clinically successful implant placement even in poorly controlled diabetic patients.</AbstractText><CopyrightInformation>© 2011 John Wiley & Sons A/S.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khandelwal</LastName><ForeName>Namita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Graduate School of Biomedical Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oates</LastName><ForeName>Thomas W</ForeName><Initials>TW</Initials></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Adriana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Peggy P</ForeName><Initials>PP</Initials></Author><Author ValidYN="Y"><LastName>Schoolfield</LastName><ForeName>John D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Alex McMahan</LastName><ForeName>C</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Clin Oral Implants Res</MedlineTA><NlmUniqueID>9105713</NlmUniqueID><ISSNLinking>0905-7161</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015921">Dental Implants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000134" MajorTopicYN="N">Acid Etching, Dental</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003758" MajorTopicYN="N">Dental Implantation, Endosseous</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015921" MajorTopicYN="Y">Dental Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017267" MajorTopicYN="Y">Dental Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007576" MajorTopicYN="N">Jaw, Edentulous, Partially</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013499" MajorTopicYN="N">Surface Properties</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>10</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22145978</ArticleId><ArticleId IdType="doi">10.1111/j.1600-0501.2011.02369.x</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D85 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000D85 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:22145978
|texte= Conventional SLA and chemically modified SLA implants in patients with poorly controlled type 2 diabetes mellitus--a randomized controlled trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:22145978" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |